\n \nDescription: \n \nMoxifloxacin is a synthetic broad spectrum, fluoroquinolone derivative antibacterial agent. Moxifloxacin has in vitro activity against a wide range of Gram-positive and Gram-negative microorganisms. The bactericidal action of Moxifloxacin results from inhibition of the topoisomerase II (DNA gyrase) and topoisomerase IV required for bacterial DNA replication, transcription, repair and recombination. \n \nComposition:?Each film-coated tablet contains Moxifloxacin Hydrochloride BP equivalent to Moxifloxacin 400 mg \n \nIndication:?Cubimox is indicated for the treatment of adults (>18 years of age) with infections caused by susceptible strains of the designated microorganisms in the conditions listed below- \n

\n
• Acute Bacterial Sinusitis
\n
• Acute Bacterial Exacerbation of Chronic Bronchitis
\n
• Community Acquired Pneumonia
\n
• Uncomplicated Skin and Skin Structure Infections
\n
• Complicated Skin and Skin Structure Infections
\n
• Complicated Intra-Abdominal Infections
\n
• Acute Pelvic Inflammatory Disease
\n

\nDosage & Administration:?The dose of Cubimox is 400 mg once every 24 hours (for adults) \n \nOr, as advised by the physician. \n \n